Somaxon Pharmaceuticals, Inc. (SOMX) announced the appointment of Tran Nguyen as Vice President and Chief Financial Officer.
Nguyen was most recently Chief Financial Officer of Metabasis Therapeutics, Inc., a publicly traded biopharmaceutical company that was acquired by Ligand Pharmaceuticals Incorporated in January 2010.
The company also announced other executive management team updates each effective April 1, 2010.
The company noted that Jeffrey Raser was promoted to the newly created role of Senior Vice President and Chief Commercial Officer. In this role, Raser will be responsible for all of Somaxon's sales, marketing, managed care and other commercial operations. Brian Dorsey was promoted to Senior Vice President, Technical Operations. In this role, Dorsey will manage all of Somaxon's activities relating to research and development, regulatory affairs, medical affairs, manufacturing and quality.
Further, Matthew Onaitis was promoted to Senior Vice President and General Counsel. In this role, Onaitis will manage all of Somaxon's legal, compliance, intellectual property and business development activities.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.